Get our guide to planning and executing an M&A communications strategy.Download Now

Westicke Partners

Close

Mary-Jane Elliott

Mary-Jane Elliott co-founded Consilium Strategic Communications in July 2013 having led the management buy-out from M:Communications. She has more than 20 years of healthcare experience from leading communications agencies and the pharmaceutical industry and is an expert in financial, corporate, investor and scientific communications.

Biography

Mary-Jane Elliott co-founded Consilium Strategic Communications in July 2013 having led the management buy-out from M:Communications. She has more than 20 years of healthcare experience from leading communications agencies and the pharmaceutical industry and is an expert in financial, corporate, investor and scientific communications. Prior to founding Consilium, Mary-Jane established and led M:Communications’ successful international healthcare team where she advised public and private companies internationally across all sub-sectors of healthcare and including some of the sector’s leading industry bodies. She has extensive experience including advising on a wide range of high profile IPOs, secondary fundraisings, private equity placements, M&A transactions, crisis communications and clinical data and product launches. Mary-Jane worked both as a scientist and PR/IR executive at PowderJect Pharmaceuticals plc from 1997-2003 and was previously with Bell Laboratories Inc in Madison, Wisconsin, US.  Mary-Jane has a BSc (Hons) in BioMedical Sciences.

Read about Westwicke’ joint venture with European partner, Consilium Strategic Communications >>

Guidance is a key component of any investor relations program.

Download our checklist of do’s and don’ts for providing effective guidance to investors and analysts. Download Now

Our Locations